To Observe the CD7-targeted CAR-T Therapy in the Treatment of r/r PTCL

Clinical trial NCT07143929 · RECRUITING

Trial details

NCT number: NCT07143929
Sponsor: Peking University People's Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

CD7 Positive R/R PTCL

Start date: 2025-08-18
Primary completion: 2026-07-31
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.